Patent details
EP3049441 Title: ANTI-PDL1 ANTIBODY FORMULATIONS
Basic Information
- Publication number:
- EP3049441
- PCT Application Number:
- US2014057821
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP147841696
- PCT Publication Number:
- WO2015048520
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- ANTI-PDL1 ANTIBODY FORMULATIONS
- French Title of Invention:
- FORMULATIONS D'ANTICORPS ANTI-PDL1
- German Title of Invention:
- ANTI-PDL1-ANTIKÖRPERFORMULIERUNGEN
- SPC Number:
Dates
- Filing date:
- 26/09/2014
- Grant date:
- 27/11/2019
- EP Publication Date:
- 03/08/2016
- PCT Publication Date:
- 02/04/2015
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 27/11/2019
- EP B1 Publication Date:
- 27/11/2019
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 26/09/2020
- Expiration date:
- 26/09/2034
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 20/11/2019
- Name:
- F. Hoffmann-La Roche AG
- Address:
- Grenzacherstrasse 124, 4070 Basel, Switzerland (CH)
Inventor
1
- Name:
- YANG, Ying
- Address:
- United States (US)
2
- Name:
- ALAVATTAM, Sreedhara
- Address:
- United States (US)
Priority
- Priority Number:
- 201361883953 P
- Priority Date:
- 27/09/2013
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 39/00; A61K 39/395; C07K 16/28;
Publication
European Patent Bulletin
- Issue number:
- 201948
- Publication date:
- 27/11/2019
- Description:
- Grant (B1)
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|